ST3gal6 Peptide |
|||
| 5169P | ProSci | 0.05 mg | EUR 197.7 |
|
Description: (CT) ST3gal6 peptide |
|||
ST3gal6 Peptide |
|||
| MBS152440-005mg | MyBiosource | 0.05mg | EUR 175 |
ST3gal6 Peptide |
|||
| MBS152440-5x005mg | MyBiosource | 5x0.05mg | EUR 770 |
ST3gal6 Antibody |
|||
| 5169-002mg | ProSci | 0.02 mg | EUR 206.18 |
|
Description: ST3gal6 Antibody: Sialyltransferases catalyze the transfer of sialic acid from cytidine 5-prime monophospho-N-acetylneuraminic acid (CMP-NeuAc) to terminal positions of glycoprotein and glycolipid carbohydrate groups. Terminal NeuAc residues are key determinants of carbohydrate structures, such as the sialyl-Lewis X determinants, and are widely distributed in many cell types. However, cancer cells often express more heavily sialylated glycans on their cell surface and this feature sometimes correlates with invasiveness. In contrast, expression of ST3gal6, a member of the sialyltransferase family that sialylates type II lactosamine structures on glycoproteins and glycolipids, was found to be significantly decreased by hypermethylation of the gene in gastrointestinal cancer. At least three isoforms of ST3gal6 are known to exist. |
|||
ST3gal6 Antibody |
|||
| 5169-01mg | ProSci | 0.1 mg | EUR 523.7 |
|
Description: ST3gal6 Antibody: Sialyltransferases catalyze the transfer of sialic acid from cytidine 5-prime monophospho-N-acetylneuraminic acid (CMP-NeuAc) to terminal positions of glycoprotein and glycolipid carbohydrate groups. Terminal NeuAc residues are key determinants of carbohydrate structures, such as the sialyl-Lewis X determinants, and are widely distributed in many cell types. However, cancer cells often express more heavily sialylated glycans on their cell surface and this feature sometimes correlates with invasiveness. In contrast, expression of ST3gal6, a member of the sialyltransferase family that sialylates type II lactosamine structures on glycoproteins and glycolipids, was found to be significantly decreased by hypermethylation of the gene in gastrointestinal cancer. At least three isoforms of ST3gal6 are known to exist. |
|||
ST3gal6 Antibody |
|||
| 24896 | SAB | 100ul | EUR 479 |
ST3gal6 Antibody |
|||
| 24896-100ul | SAB | 100ul | EUR 468 |
ST3GAL6 Antibody |
|||
| DF14982 | Affbiotech | 100ul | EUR 420 |
ST3GAL6 Antibody |
|||
| DF14982-100ul | Affinity Biosciences | 100ul | EUR 168 |
|
Description: IHC,IF/ICC,ELISA(peptide) |
|||
ST3GAL6 Antibody |
|||
| DF14982-200ul | Affinity Biosciences | 200ul | EUR 210 |
|
Description: IHC,IF/ICC,ELISA(peptide) |
|||
ST3GAL6 Antibody |
|||
| 1-CSB-PA022756GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against ST3GAL6. Recognizes ST3GAL6 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB |
|||
ST3GAL6 Antibody |
|||
| E94414 | EnoGene | 100μg | EUR 255 |
|
Description: Available in various conjugation types. |
|||
ST3gal6 Antibody |
|||
| MBS150396-01mg | MyBiosource | 0.1mg | EUR 445 |
ST3gal6 Antibody |
|||
| MBS150396-5x01mg | MyBiosource | 5x0.1mg | EUR 1965 |
ST3GAL6 Antibody |
|||
| MBS9632653-1mg | MyBiosource | 1mg | EUR 375 |
ST3GAL6 Antibody |
|||
| MBS9632653-5x1mg | MyBiosource | 5x1mg | EUR 1545 |
ST3GAL6 Antibody |
|||
| MBS9630270-01mL | MyBiosource | 0.1mL | EUR 260 |
ST3GAL6 Antibody |
|||
| MBS9630270-02mL | MyBiosource | 0.2mL | EUR 305 |
ST3GAL6 Antibody |
|||
| MBS9630270-5x02mL | MyBiosource | 5x0.2mL | EUR 1220 |
ST3GAL6 Antibody |
|||
| MBS8503617-01mg | MyBiosource | 0.1mg | EUR 325 |
ST3GAL6 Antibody |
|||
| MBS8503617-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
ST3GAL6 Antibody |
|||
| MBS8503617-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
ST3GAL6 Antibody |
|||
| MBS8503617-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
ST3GAL6 Antibody |
|||
| MBS8503617-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
ST3gal6 Antibody |
|||
| MBS9400835-01mL | MyBiosource | 0.1mL | EUR 495 |
ST3gal6 Antibody |
|||
| MBS9400835-5x01mL | MyBiosource | 5x0.1mL | EUR 2075 |
ST3GAL6 antibody |
|||
| 70R-20550 | Fitzgerald Industries International | 50 ul | Ask for price |
Mouse ST3GAL6 siRNA |
|||
| 20-abx935322 | Abbexa |
|
|
Human ST3GAL6 siRNA |
|||
| 20-abx935323 | Abbexa |
|
|
ST3GAL6 siRNA (Human) |
|||
| MBS8204102-15nmol | MyBiosource | 15nmol | EUR 405 |
ST3GAL6 siRNA (Human) |
|||
| MBS8204102-30nmol | MyBiosource | 30nmol | EUR 565 |
ST3GAL6 siRNA (Human) |
|||
| MBS8204102-5x30nmol | MyBiosource | 5x30nmol | EUR 2450 |
ST3GAL6 siRNA (Mouse) |
|||
| MBS8238998-15nmol | MyBiosource | 15nmol | EUR 405 |
ST3GAL6 siRNA (Mouse) |
|||
| MBS8238998-30nmol | MyBiosource | 30nmol | EUR 565 |
ST3GAL6 siRNA (Mouse) |
|||
| MBS8238998-5x30nmol | MyBiosource | 5x30nmol | EUR 2450 |
anti- ST3GAL6 antibody |
|||
| FNab08267 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against ST3GAL6 |
|||
pcDNA3.1(-)-ST3GAL6 Plasmid |
|||
| PVTB00893-2a | Lifescience Market | 2 ug | EUR 427.2 |
Human ST3GAL6 ELISA KIT |
|||
| ELI-15582h | Lifescience Market | 96 Tests | EUR 988.8 |
Mouse St3gal6 ELISA KIT |
|||
| ELI-15583m | Lifescience Market | 96 Tests | EUR 1038 |
ST3GAL6 ELISA KIT|Human |
|||
| EF003265 | Lifescience Market | 96 Tests | EUR 826.8 |
Bovine ST3GAL6 ELISA KIT |
|||
| ELI-36075b | Lifescience Market | 96 Tests | EUR 1113.6 |
ST3GAL6 (untagged)-Human ST3 beta-galactoside alpha-2,3-sialyltransferase 6 (ST3GAL6) |
|||
| SC116324 | Origene Technologies GmbH | 10 µg | Ask for price |
ST3GAL6 (untagged)-Human ST3 beta-galactoside alpha-2,3-sialyltransferase 6 (ST3GAL6) |
|||
| SC322551 | Origene Technologies GmbH | 10 µg | Ask for price |
Human ST3GAL6 shRNA Plasmid |
|||
| 20-abx957051 | Abbexa |
|
|
Mouse ST3GAL6 shRNA Plasmid |
|||
| 20-abx974525 | Abbexa |
|
|
Human ST3GAL6 Protein Lysate |
|||
| MBS8427914-INQUIRE | MyBiosource | INQUIRE | Ask for price |
ST3GAL6 Peptide - middle region |
|||
| MBS3247366-01mg | MyBiosource | 0.1mg | EUR 180 |
ST3GAL6 Peptide - middle region |
|||
| MBS3247366-5x01mg | MyBiosource | 5x0.1mg | EUR 730 |
ST3GAL6 Peptide - middle region |
|||
| MBS3246205-01mg | MyBiosource | 0.1mg | EUR 180 |
ST3GAL6 Peptide - middle region |
|||
| MBS3246205-5x01mg | MyBiosource | 5x0.1mg | EUR 730 |
St3gal6 Peptide - middle region |
|||
| MBS3245335-01mg | MyBiosource | 0.1mg | EUR 180 |
St3gal6 Peptide - middle region |
|||
| MBS3245335-5x01mg | MyBiosource | 5x0.1mg | EUR 730 |
ST3GAL6 Antibody - middle region |
|||
| MBS3222699-01mL | MyBiosource | 0.1mL | EUR 455 |
ST3GAL6 Antibody - middle region |
|||
| MBS3222699-5x01mL | MyBiosource | 5x0.1mL | EUR 1995 |
ST3GAL6 Antibody - middle region |
|||
| MBS3220533-01mL | MyBiosource | 0.1mL | EUR 455 |
ST3GAL6 Antibody - middle region |
|||
| MBS3220533-5x01mL | MyBiosource | 5x0.1mL | EUR 1995 |
ST3GAL6 Antibody - middle region |
|||
| MBS3221471-01mL | MyBiosource | 0.1mL | EUR 455 |
ST3GAL6 Antibody - middle region |
|||
| MBS3221471-5x01mL | MyBiosource | 5x0.1mL | EUR 1995 |
ST3GAL6 Recombinant Protein (Rat) |
|||
| RP231248 | ABM | 100 ug | Ask for price |
St3gal6 (untagged) - Mouse ST3 beta-galactoside alpha-2,3-sialyltransferase 6 (St3gal6), (10ug) |
|||
| MC204731 | Origene Technologies GmbH | 10 µg | Ask for price |
St3gal6 (GFP-tagged) - Mouse ST3 beta-galactoside alpha-2,3-sialyltransferase 6 (St3gal6) |
|||
| MG204835 | Origene Technologies GmbH | 10 µg | Ask for price |
ST3GAL6 (GFP-tagged) - Human ST3 beta-galactoside alpha-2,3-sialyltransferase 6 (ST3GAL6) |
|||
| RG205750 | Origene Technologies GmbH | 10 µg | Ask for price |
ST3GAL6 (NM_006100) Human Recombinant Protein |
|||
| E45H39212M5 | EnoGene | 20 ug | EUR 785.42 |
St3gal6 (NM_018784) Mouse Recombinant Protein |
|||
| E45M47225M5 | EnoGene | 20 ug | EUR 1924.54 |
ST3GAL6 (NM_006100) Human Recombinant Protein |
|||
| PROTQ9Y274 | BosterBio | 20ug | EUR 1249 |
|
Description: Recombinant protein of human ST3 beta-galactoside alpha-2,3-sialyltransferase 6 (ST3GAL6) |
|||
ST3GAL6 Recombinant Protein (Mouse) |
|||
| RP175769 | ABM | 100 ug | Ask for price |
ST3GAL6 Recombinant Protein (Human) |
|||
| RP100368 | ABM | 100 ug | Ask for price |
OAPB00889-100UG - ST3gal6 Antibody |
|||
| OAPB00889-100UG | Aviva Systems Biology | 0.1mg | EUR 389 |
Rabbit Polyclonal ST3gal6 Antibody |
|||
| TA306781 | Origene Technologies GmbH | 100 µg | Ask for price |
St3gal6 ORF Vector (Rat) (pORF) |
|||
| ORF077084 | ABM | 1.0 ug DNA | EUR 607.2 |
ST3GAL6 ORF Vector (Human) (pORF) |
|||
| ORF033457 | ABM | 1.0 ug DNA | EUR 486 |
St3gal6 ORF Vector (Mouse) (pORF) |
|||
| ORF058591 | ABM | 1.0 ug DNA | EUR 607.2 |
St3gal6 (Myc-DDK-tagged) - Mouse ST3 beta-galactoside alpha-2,3-sialyltransferase 6 (St3gal6) |
|||
| MR204835 | Origene Technologies GmbH | 10 µg | Ask for price |
ST3GAL6 (Myc-DDK-tagged)-Human ST3 beta-galactoside alpha-2,3-sialyltransferase 6 (ST3GAL6) |
|||
| RC205750 | Origene Technologies GmbH | 10 µg | Ask for price |
Mouse St3gal6 qPCR Primer Pair |
|||
| QM27690S | Beyotime Biotech Inc | 200 Tests | Ask for price |
Human ST3GAL6 qPCR Primer Pair |
|||
| QH31345S | Beyotime Biotech Inc | 200 Tests | Ask for price |
Human ST3GAL6 knockout cell line |
|||
| ABC-KH14737 | AcceGen | 1 vial | Ask for price |
|
Description: Human ST3GAL6 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
|||
St3gal6 (untagged ORF) - Rat ST3 beta-galactoside alpha-2,3-sialyltransferase 6 (St3gal6), (10 ug) |
|||
| RN205995 | Origene Technologies GmbH | 10 µg | Ask for price |
Human ST3GAL6 knockdown cell line |
|||
| ABC-KD14737 | AcceGen | 1 vial | Ask for price |
|
Description: Human ST3GAL6 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
|||
Human ST3GAL6 Protein Lysate 20ug |
|||
| IHUST3GAL6PLLY20UG | Innovative research | each | EUR 211 |
|
Description: Human ST3GAL6 Protein Lysate 20ug |
|||
ST3GAL6 ELISA Kit (Human) (OKEH08555) |
|||
| OKEH08555 | Aviva Systems Biology | 96 Wells | EUR 1075.2 |
|
Description: Description of target: The protein encoded by this gene is a member of the sialyltransferase family. Members of this family are enzymes that transfer sialic acid from the activated cytidine 5'-monophospho-N-acetylneuraminic acid to terminal positions on sialylated glycolipids (gangliosides) or to the N- or O-linked sugar chains of glycoproteins. This protein has high specificity for neolactotetraosylceramide and neolactohexaosylceramide as glycolipid substrates and may contribute to the formation of selectin ligands and sialyl Lewis X, a carbohydrate important for cell-to-cell recognition and a blood group antigen.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.39ng/mL |
|||
ST3GAL6 (NM_006100) Human Over-expression Lysate |
|||
| E45H08034-2 | EnoGene | each | EUR 395 |
ST3GAL6 (NM_006100) Human Over-expression Lysate |
|||
| LS010402 | BosterBio | 100ug | EUR 628 |
|
Description: Transient overexpression lysate of ST3 beta-galactoside alpha-2,3-sialyltransferase 6 (ST3GAL6) |
|||
ST3GAL6 (untagged) - Human ST3 beta-galactoside alpha-2,3-sialyltransferase 6 (ST3GAL6), transcript variant 6 |
|||
| SC334293 | Origene Technologies GmbH | 10 µg | Ask for price |
ST3GAL6 (untagged) - Human ST3 beta-galactoside alpha-2,3-sialyltransferase 6 (ST3GAL6), transcript variant 2 |
|||
| SC334788 | Origene Technologies GmbH | 10 µg | Ask for price |